Form 4 Tracker
CRISPR Therapeutics AG
CRSP

37 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 19, 2026Feb 20 10:36 PMSamarth KulkarniDirector, Chief Executive Officer
Sale
6,967$52.58$366.3K226,106(D)

View →

Feb 19, 2026Feb 20 10:35 PMJames R. KasingerGeneral Counsel and Secretary
Sale
2,112$52.58$111.0K85,115(D)

View →

Apr 3, 2025Jan 27 10:35 PMNaimish PatelChief Medical Officer
Purchase
1,508$32.96$49.7K1,508(D)

View →

Jan 22, 2026Jan 26 10:35 PMRaju PrasadChief Financial Officer
Sale
34,972$60.19$2.1M6,767(D)

View →

Jan 22, 2026Jan 22 10:55 PMSamarth KulkarniDirector, Chief Executive Officer
Sale
60,000$60.23$3.6M134,201(D)

View →

Jan 20, 2026Jan 22 10:55 PMSamarth KulkarniDirector, Chief Executive Officer
Sale
30,000$51.75$1.6M194,201(D)

View →

Jan 22, 2026Jan 22 10:15 PMSamarth Kulkarni
Proposed Sale
60,000$60.81$3.6M—

View →

Jan 22, 2026Jan 22 9:03 PMRAJU PRASAD
Proposed Sale
34,972$60.19$2.1M—

View →

Jan 20, 2026Jan 20 10:11 PMSamarth Kulkarni
Proposed Sale
30,000$52.61$1.6M—

View →

Jan 6, 2026Jan 6 10:11 PMRAJU PRASAD
Proposed Sale
29,700$60.16$1.8M—

View →

Dec 22, 2025Dec 22 9:20 PMRAJU PRASAD
Proposed Sale
10,000$55.95$559.5K—

View →

Feb 18, 2025Feb 18 10:35 PMSamarth Kulkarni
Proposed Sale
45,000$52.22$2.3M—

View →

Nov 11, 2024Nov 12 1:07 PMDr. Samarth Kulkarni
Proposed Sale
75,000$54.86$4.1M—

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 20, 2026Mar 24 9:38 PMJames R. KasingerGeneral Counsel and Secretary
Option Exercise
6,250—12,000(D)

View →

Mar 20, 2026Mar 24 9:38 PMJames R. KasingerGeneral Counsel and Secretary
Grant/Award
63,499$46.2425,000(D)

View →

Mar 20, 2026Mar 24 9:37 PMSamarth KulkarniDirector, Chief Executive Officer
Grant/Award
196,124$46.2481,875(D)

View →

Mar 20, 2026Mar 24 9:37 PMSamarth KulkarniDirector, Chief Executive Officer
Option Exercise
19,687—39,375(D)

View →

Mar 20, 2026Mar 24 9:37 PMRaju PrasadChief Financial Officer
Option Exercise
6,250—12,500(D)

View →

Mar 20, 2026Mar 24 9:37 PMRaju PrasadChief Financial Officer
Grant/Award
65,999$46.2427,500(D)

View →

Mar 20, 2026Mar 24 9:36 PMNaimish PatelChief Medical Officer
Grant/Award
68,499$46.2430,000(D)

View →

Mar 14, 2026Mar 17 9:37 PMNaimish PatelChief Medical Officer
Option Exercise
8,125—24,375(D)

View →

Mar 14, 2026Mar 17 9:37 PMRaju PrasadChief Financial Officer
Option Exercise
16,875—20,625(D)

View →

Mar 14, 2026Mar 17 9:35 PMJames R. KasingerGeneral Counsel and Secretary
Option Exercise
6,875—20,625(D)

View →

Mar 14, 2026Mar 17 9:35 PMSamarth KulkarniDirector, Chief Executive Officer
Option Exercise
20,625—61,875(D)

View →

Mar 10, 2026Mar 12 9:35 PMJames R. KasingerGeneral Counsel and Secretary
Option Exercise
5,500—5,500(D)

View →

Mar 10, 2026Mar 12 9:35 PMSamarth KulkarniDirector, Chief Executive Officer
Option Exercise
19,250—19,250(D)

View →

Feb 18, 2026Feb 20 10:36 PMSamarth KulkarniDirector, Chief Executive Officer
Option Exercise
13,250—0(D)

View →

Feb 18, 2026Feb 20 10:35 PMJames R. KasingerGeneral Counsel and Secretary
Option Exercise
3,825—0(D)

View →

Jan 22, 2026Jan 26 10:35 PMRaju PrasadChief Financial Officer
Option Exercise
34,972$45.1541,667(D)

View →

← Previous

Page 2 of 2